ELCC24
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ELCC24
Jul 14, 2024, 07:21 |
Drugs
Drug list Ver 3 for mNSCLC: 1st line EGFR common mutations
Katsuaki Maehara, Director of Medical Education Colleagues, shared on X: "Lung - NSCLC Drug list…
Mar 29, 2024, 22:30 |
Blog
Brendon Stiles: Let's talk about PACIFIC 2
Brendon Stiles, Professor and Chief, Thoracic Surgery and Surgical Oncology at Montefiore Health System, posted…
Mar 28, 2024, 19:34 |
Societies
Cecilia Pompili: Personalized care in lung cancer will not be possible without multidisciplinary team and collaboration between specialities as we have seen during ELCC24
Mar 27, 2024, 14:11 |
Blog
Stephen V Liu: ELCC24 Great discussion of Antibody drug conjugates toxicity from Dr. Jarushka Naidoo, noting that each component of the antibody drug conjugate will impact toxicity
Mar 27, 2024, 00:22 |
Blog
Elene Mariamidze: Yoc mentorship sessions at ELCC24
Elene Mariamidze, Medical/Clinical Oncologist at Todua Clinic, shared the following post on X: "Yoc mentorship…
Mar 25, 2024, 15:14 |
Societies
Giannis Mountzios: ELCC24, Daniel Tan performs a deep dive in Bi-specific Abs/BiteS/T-cell engagers in NSCLC
Giannis Mountzios, Consultant Medical Oncologist at the Department of Medical Oncology in the Air Force…
Mar 25, 2024, 15:09 |
Insight
Jarushka Naidoo: Surgical outcomes of RATIONALE-315 (Neoadjuvant Tis + chemo in resectable NSCLC)
Jarushka Naidoo recently posted on X: "Surgical outcomes of RATIONALE-315 (Neoadjuvant Tis+chemo in resectable NSCLC): -…
Mar 25, 2024, 06:01 |
Insight
Vivek Subbiah: For patients with NSCLC, initial use of SGT increases subsequent CGP test cancellations
Vivek Subbiah recently posted on X: "Just published in time for the ELCC24: The Impact of…
Mar 24, 2024, 23:26 |
Blog
Jarushka Naidoo: ESMO Young Oncologists (YO) session on career navigation with Herbert Loong, Lizza Hendriks, Alfredo Addeo & I
Jarushka Naidoo shared a post on X: “ELCC24 ESMO Young Oncologists (YO) session on career…
Mar 23, 2024, 15:01 |
Societies
Giuseppe Viscardi: Our work led by Roberto Ferrara on waning effect of EGFR TKIs in adjuvant setting won best poster award
Giuseppe Viscardi, Lung Oncologist at Monaldi Hospital in Naples, shared on X/Twitter: “Great news from…
Mar 23, 2024, 14:54 |
Societies
Rui Fu: Enjoying the opportunity to exchange ideas with fellow researchers at ELCC24
Rui Fu, Lung Cancer Researcher and Thoracic Cancer Surgeon at Guangdong Provincial People’s Hospital, on…
Mar 23, 2024, 13:08 |
Blog
Herbert Loong: Always a pleasure to share session with my Partner In Crime at Princess Margaret Cancer Centre Canada, Alona Zer
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared a post on…
All:
12
Posts:
1 - 100
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube